The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission ...
Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.